Access to Whole-Genome Sequencing for Genetic Disease Testing :Illumina and Harvard Pilgrim Health Care Kumar Jeetendra | December 20, 2020 SAN DIEGO & WELLESLEY, Mass.–(BUSINESS WIRE)– Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey …
